Table 1.
R | R′ | log IC50 (M) | IC50 (μM) | ΔY | |
---|---|---|---|---|---|
5a | —OCH2CH3 | —CH3 | ndb | >2500c | - |
5b | —OCH3 | —CH3 | nd | >3000c | - |
5c | —OC(CH3)3 | —CH3 | nd | >3000c | - |
5d | —OCH2 CH2OCH3 | —CH3 | nd | >2000c | - |
5e | —OCH2CH3 | —CH2CH3 | −1.7±0.2d | 20560±8500 | 0.60 |
5f | —OCH2CH3 | —CH(CH3)2 | −1.9±0.3 | 13650±10400 | 0.75 |
5g | —OCH2CH3 | —CH2OCH3 | nd | >16000c | - |
5h | —OCH2CH3 | Morpholine-4-carbonyl | nd | >25,000c | - |
5i | —OCH2CH3 | Benzoyl-p-methoxy | −3.3±0.2 | 520±280 | 0.54 |
5j | —OCH2CH=CH2 | —CH3 | nd | >3000 | - |
9a | N-morpholino | —CH3 | nd | >2000c | - |
9b | N-piperidino | —CH3 | nd | >2000c | - |
10e | —CH2CH3 | —CH3 | nd | >7000c | - |
Thrombin inhibition was measured in spectrophotometric assay through initial rate of Spectrozyme TH hydrolysis as described in Experimental section.
Not determined due to incomplete and/or poor inhibition.
Estimates on the basis of the highest concentration used in experiment.
standard error shown is ±1 S.E.
10 contains a morpholine group at the allylic position (instead of a –CH3 group). See Figure 2 for the full structure.